Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris
- PMID: 1486893
- DOI: 10.1007/BF01962381
Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris
Abstract
The antibacterial activity of the topical quinolone OPC-7251 against bacteria commonly found in acne vulgaris was tested in vitro by an agar dilution method. The MIC50 was 0.25 mg/l for Propionibacterium acnes, 0.125 mg/l for Propionibacterium granulosum, 0.03 mg/l for Staphylococcus aureus and 0.06 mg/l for coagulase-negative staphylococci. Compared with seven other antibiotics tested (ciprofloxacin, penicillin, erythromycin, tetracycline, clindamycin, fusidic acid and gentamicin), OPC-7251 had potent activity against both propionibacteria and staphylococci and the lowest incidence of resistant strains.
Similar articles
-
Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris.Drugs. 1995;49 Suppl 2:266-8. doi: 10.2165/00003495-199500492-00065. Drugs. 1995. PMID: 8549327 No abstract available.
-
Antimicrobial activities of ozenoxacin against isolates of propionibacteria and staphylococci from Japanese patients with acne vulgaris.J Med Microbiol. 2016 Aug;65(8):745-750. doi: 10.1099/jmm.0.000293. Epub 2016 Jun 15. J Med Microbiol. 2016. PMID: 27305898
-
Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.J Int Med Res. 1996 Nov-Dec;24(6):473-7. doi: 10.1177/030006059602400604. J Int Med Res. 1996. PMID: 8959531 Clinical Trial.
-
[Anti-microbial therapies for acne vulgaris: anti-inflammatory actions of anti-microbial drugs and their effectiveness].J UOEH. 2007 Mar 1;29(1):63-71. doi: 10.7888/juoeh.29.63. J UOEH. 2007. PMID: 17380730 Review. Japanese.
-
An overview of topical antibiotics for acne treatment.Dermatology. 1998;196(1):130-4. doi: 10.1159/000017846. Dermatology. 1998. PMID: 9557247 Review.
Cited by
-
Efficacy and safety of nadifloxacin for bacterial skin infections: results from clinical and post-marketing studies.Dermatol Ther (Heidelb). 2014 Dec;4(2):233-48. doi: 10.1007/s13555-014-0062-1. Epub 2014 Sep 12. Dermatol Ther (Heidelb). 2014. PMID: 25212256 Free PMC article.
-
Transdermal penetration of topical drugs used in the treatment of acne.Clin Pharmacokinet. 2003;42(14):1287-304. doi: 10.2165/00003088-200342140-00005. Clin Pharmacokinet. 2003. PMID: 14606932 Review.
-
Activity of newer fluoroquinolones in vitro against gram-positive bacteria.Drugs. 1999;58 Suppl 2:23-8. doi: 10.2165/00003495-199958002-00005. Drugs. 1999. PMID: 10553701
-
Glycosides of Nadifloxacin-Synthesis and Antibacterial Activities against Methicillin-Resistant Staphylococcus aureus.Molecules. 2022 Feb 23;27(5):1504. doi: 10.3390/molecules27051504. Molecules. 2022. PMID: 35268604 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources